Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]

  Female cancer patients at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, have a new option to preserve their fertility before undergoing treatment. “It is extremely common that cancer patients will experience the loss of fertility and early menopause after gonadotoxic therapies required for many cancer patients,” said […]

  Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]